Loading...
XNAS
TNDM
Market cap1.42bUSD
Dec 05, Last price  
20.92USD
1D
1.01%
1Q
66.30%
Jan 2017
-2.70%
IPO
-4.21%
Name

Tandem Diabetes Care Inc

Chart & Performance

D1W1MN
XNAS:TNDM chart
P/E
P/S
1.51
EPS
Div Yield, %
Shrs. gr., 5y
2.27%
Rev. gr., 5y
21.01%
Revenues
940m
+25.74%
02,474,69829,006,63849,722,00072,850,00084,248,000107,601,000183,866,000362,305,000498,830,000702,799,000801,217,000747,718,000940,203,000
Net income
-96m
L-56.86%
-25,509,824-33,015,085-63,138,849-79,524,000-72,418,000-83,447,000-73,033,000-122,611,000-24,753,000-34,382,00015,566,000-94,594,000-222,611,000-96,025,000
CFO
24m
P
-21,546,786-33,471,166-47,756,651-61,378,000-58,764,000-61,173,000-66,136,000-8,319,00041,905,00024,669,000111,359,00050,464,000-31,810,00024,225,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
IPO date
Nov 13, 2013
Employees
2,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT